Karn Wijarnpreecha1, Susan Lou2, Panadeekarn Panjawatanan3, Wisit Cheungpasitporn4, Surakit Pungpapong5, Frank J Lukens5, Patompong Ungprasert6. 1. Department of Internal Medicine, Bassett Medical Center, Cooperstown, NY, USA; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Jacksonville, FL, USA. 2. Department of Medicine, University of Minnesota, Minneapolis, MN, USA. 3. Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. 4. Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, MS, United States. 5. Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Jacksonville, FL, USA. 6. Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Electronic address: p.ungprasert@gmail.com.
Abstract
BACKGROUND/ OBJECTIVES: Recent studies have suggested an association between nonalcoholic fatty liver disease (NAFLD) and diastolic cardiac dysfunction, although the results were inconsistent. This study was conducted to investigate this possible association. METHODS: A comprehensive literature review was conducted utilizing the MEDLINE and Embase databases from inception through May 2018 to identify all cross-sectional studies that compared the prevalence of diastolic cardiac dysfunction among patients with NAFLD to individuals without NAFLD. Effect estimates from each study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird. RESULTS: A total of 12 studies with 280,645 participants fulfilled the eligibility criteria and were included in the meta-analysis. There was a significant association between NAFLD and diastolic cardiac dysfunction with a pooled odds ratio (OR) of 2.02 (95% confidence interval (CI), 1.47-2.79; I2 89%). Subgroup analysis based on the country of origin continued to demonstrate a significant association in subgroups of both Western and Eastern countries with pooled ORs of 1.76 (95% CI, 1.14-2.72; I2 85%) and 2.59 (95% CI, 1.42-4.69; I2 87%), respectively. Limitations included high between-study heterogeneity, lack of unified definition of diastolic dysfunction and presence of publication bias. CONCLUSIONS: A significant association between diastolic cardiac dysfunction and NAFLD was observed in this meta-analysis. This observation could suggest the need for careful cardiovascular surveillance among patients with NAFLD.
BACKGROUND/ OBJECTIVES: Recent studies have suggested an association between nonalcoholic fatty liver disease (NAFLD) and diastolic cardiac dysfunction, although the results were inconsistent. This study was conducted to investigate this possible association. METHODS: A comprehensive literature review was conducted utilizing the MEDLINE and Embase databases from inception through May 2018 to identify all cross-sectional studies that compared the prevalence of diastolic cardiac dysfunction among patients with NAFLD to individuals without NAFLD. Effect estimates from each study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird. RESULTS: A total of 12 studies with 280,645 participants fulfilled the eligibility criteria and were included in the meta-analysis. There was a significant association between NAFLD and diastolic cardiac dysfunction with a pooled odds ratio (OR) of 2.02 (95% confidence interval (CI), 1.47-2.79; I2 89%). Subgroup analysis based on the country of origin continued to demonstrate a significant association in subgroups of both Western and Eastern countries with pooled ORs of 1.76 (95% CI, 1.14-2.72; I2 85%) and 2.59 (95% CI, 1.42-4.69; I2 87%), respectively. Limitations included high between-study heterogeneity, lack of unified definition of diastolic dysfunction and presence of publication bias. CONCLUSIONS: A significant association between diastolic cardiac dysfunction and NAFLD was observed in this meta-analysis. This observation could suggest the need for careful cardiovascular surveillance among patients with NAFLD.
Authors: Abdulrahman Ismaiel; Mihail Spinu; Daniel-Corneliu Leucuta; Stefan-Lucian Popa; Bogdan Augustin Chis; Mihaela Fadgyas Stanculete; Dan Mircea Olinic; Dan L Dumitrascu Journal: J Clin Med Date: 2022-04-28 Impact factor: 4.964
Authors: Milton Packer; Carolyn S P Lam; Lars H Lund; Mathew S Maurer; Barry A Borlaug Journal: Eur J Heart Fail Date: 2020-06-26 Impact factor: 15.534
Authors: Anthony E Peters; Ambarish Pandey; Colby Ayers; Kara Wegermann; Robert W McGarrah; Justin L Grodin; Manal F Abdelmalek; Tarek Bekfani; Vanessa Blumer; Anna Mae Diehl; Cynthia A Moylan; Marat Fudim Journal: ESC Heart Fail Date: 2021-02-14
Authors: Marat Fudim; Lin Zhong; Kershaw V Patel; Rohan Khera; Manal F Abdelmalek; Anna Mae Diehl; Robert W McGarrah; Jeroen Molinger; Cynthia A Moylan; Vishal N Rao; Kara Wegermann; Ian J Neeland; Ethan A Halm; Sandeep R Das; Ambarish Pandey Journal: J Am Heart Assoc Date: 2021-11-10 Impact factor: 5.501
Authors: Lisa B VanWagner; Jane E Wilcox; Hongyan Ning; Cora E Lewis; John Jeffrey Carr; Mary E Rinella; Sanjiv J Shah; Joao A C Lima; Donald M Lloyd-Jones Journal: J Am Heart Assoc Date: 2020-02-06 Impact factor: 5.501
Authors: Jake P Mann; Paul Carter; Matthew J Armstrong; Hesham K Abdelaziz; Hardeep Uppal; Billal Patel; Suresh Chandran; Ranjit More; Philip N Newsome; Rahul Potluri Journal: PLoS One Date: 2020-10-27 Impact factor: 3.240